Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The glycogen metabolism pathway in lactic acid bacteria involves the uptake of carbon sources, their conversion to glucose-1-phosphate, and subsequent synthesis of glycogen via a series of enzymes including phosphoglucomutase, ADP-glucose pyrophosphorylase (GlgC), glycogen synthase (GlgA), and glycogen branching enzyme (GlgB)[1][2][3][5]. Glycogen is stored intracellularly and acts as a survival resource during periods of nutrient deprivation, environmental stress, or in competitive host environments. Induction of glycogen synthesis, for instance by growing LAB on raffinose or trehalose, is associated with improved growth, bile resistance, and gastrointestinal tract persistence[1][2][3][6]. The overall concept is not a molecular "target" but rather a strategy to enhance the physiological robustness of probiotic LAB strains through manipulation of their central carbohydrate metabolism.
Not applicable for drugs; mechanism in context is induction of glycogen synthesis by providing appropriate carbon sources (e.g., raffinose, trehalose), which enhances LAB survival and stress tolerance
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glycogen metabolism pathway in lactic acid bacteria.